Technology

Sandoz signs on to lead launch of Pear's digital therapeutics

Sandoz signs on to lead launch of Pear's digital therapeutics

By

A deal with Sandoz to lead the global launch of Pear's two lead products puts marketing muscle behind the nascent class of 'prescription digital therapeutics.'

Facebook share price rebounds after Zuckerberg's testimony

Facebook share price rebounds after Zuckerberg's testimony

Despite the US Congress's lack of insight into Facebook's operations, Mark Zuckerberg's handling of the situation seems to have restored investor confidence in the company.

Interview | Scott Dulitz, TrialCard

Interview | Scott Dulitz, TrialCard

By

Scott Dulitz, SVP, Corporate Strategy, Business Development for TrialCard, outlines how embracing the modern hub allows brands to reach their full potential.

Standing out in the era of value-based healthcare marketing

Standing out in the era of value-based healthcare marketing

With healthcare evolving from a fee-for-service system toward one that bases payment on outcomes, marketers must speak to customers in value-oriented messages.

HealthSpark 2018 unites disruptors at SXSW

HealthSpark 2018 unites disruptors at SXSW

AI, wearables, and VR still reign supreme in the healthcare realm, and other things you missed

Infographic | AI's impact on patients and caregivers

Infographic | AI's impact on patients and caregivers

By

Caregivers and patients predict how the use of AI will affect them.

Cannes Lions names new chairman

Cannes Lions names new chairman

Philip Thomas takes over from Terry Savage.

AI's marketing problem: Inflated claims, outsized expectations may actually be slowing AI's move into clinical practice

AI's marketing problem: Inflated claims, outsized expectations may actually be slowing AI's move into clinical practice

By

The potential is real, but companies and technology gurus often speak of machine learning as a catch-all solution. The hype may be slowing AI's incremental growth in healthcare, experts say.

 MM&M announces its 2018 Healthcare Transformer and Innovation Catalyst honorees

MM&M announces its 2018 Healthcare Transformer and Innovation Catalyst honorees

By

MM&M has announced its annual showcase of executives, investors, entrepreneurs, designers and thinkers who are ushering the industry into its new technological golden era.

What is a digital medicine, exactly? Akili co-founder Adam Gazzaley explains

What is a digital medicine, exactly? Akili co-founder Adam Gazzaley explains

By

MM&M spoke with Gazzaley about what's next for Akili, how he defines "digital medicine," and where the field is currently positioned on the hype cycle.

Rise of the health-tech ethicist

Rise of the health-tech ethicist

Want to get an ethicist agitated? Mention the integration of voice-activation and other tech into healthcare. Experts say navigating this area is a work in progress.

From Muse: Michelle Obama on making consumers comfortable with med tech (and thinking before she tweets)

From Muse: Michelle Obama on making consumers comfortable with med tech (and thinking before she tweets)

By

The former first lady spoke at Klick Health's Muse event, which also featured panels on gene therapy, health technology, and immunotherapy.

The doctor is always in as Heal CEO aims to revolutionize the healthcare sector

The doctor is always in as Heal CEO aims to revolutionize the healthcare sector

Heal CEO Nick Desai aims to improve the patient experience by providing an on-demand service that cuts time and costs while increasing human interaction.

Virta Health CEO Sami Inkinen on changing patient behavior: 'We're cutting down trees in the wrong forest'

Virta Health CEO Sami Inkinen on changing patient behavior: 'We're cutting down trees in the wrong forest'

By

Seven questions for the Virta Health chief executive and cofounder of Trulia.

Medtronic hires Gregory Zimprich as financial comms director

Medtronic hires Gregory Zimprich as financial comms director

Zimprich joins from Honeywell, where he led global business communications.

Real-world evidence: It's finally having its moment

Real-world evidence: It's finally having its moment

By

Fueled by system-wide demand and facilitated by AI, the industry's lofty expectations around real-world evidence could soon be fulfilled

Amazon's ability to attract other employers makes its healthcare coalition very formidable, experts say

Amazon's ability to attract other employers makes its healthcare coalition very formidable, experts say

By

Details are vague, but the e-commerce giant indicated it's serious about getting into healthcare.

Google: slow mobile pages will hurt your ranking

Google: slow mobile pages will hurt your ranking

By

Advertisers have until July to get their mobile pages up to speed.

Five things for pharma marketers to know: Wednesday, January 17, 2018

Five things for pharma marketers to know: Wednesday, January 17, 2018

By

Celgene reportedly in talks to buy Juno; Novartis' Kymriah receives fast-track reviews in U.S. and Europe; BI's Gilotrif gets expanded approval in lung cancer

No Female Keynotes at CES but Alexa's Voice was Heard Above All Others

No Female Keynotes at CES but Alexa's Voice was Heard Above All Others

The tech that's most likely to survive post-CES hype is voice but brands should rethink their gendered approach.

Can digital tools really change patient behavior?

Can digital tools really change patient behavior?

By

New research calls into question the behavioral effects of some digital health tools.

Five things for pharma marketers to know: Thursday, January 11, 2018

Five things for pharma marketers to know: Thursday, January 11, 2018

By

Novartis Oncology taps Pfizer exec as CEO; healthcare jobs become the largest source of U.S. employment; HHS nominee wary about drug-pricing negotiations

Five things for pharma marketers to know: Wednesday, January 10, 2018

Five things for pharma marketers to know: Wednesday, January 10, 2018

By

Maker of Botox biosimilar Evolus files IPO; pharma execs expect major acquisitions in 2018; J&J and Bayer win Xarelto reversal verdict

No Google, no problem: Pharma partners with China's tech giants

No Google, no problem: Pharma partners with China's tech giants

By

In the absence of behemoths such as Facebook and Twitter, pharma is partnering with China's tech giants to snare a slice of a more than $100 billion market

MM&M launches 2018 search for Healthcare Transformers and Innovation Catalysts

MM&M launches 2018 search for Healthcare Transformers and Innovation Catalysts

By

MM&M is calling for nominations for the 2018 class of Top 40 Healthcare Transformers and is seeking industry input for the Top 10 Innovation Catalysts.

Bank brand creates own algorithm to avoid YouTube ad pitfalls

Bank brand creates own algorithm to avoid YouTube ad pitfalls

By

US bank JPMorgan Chase has returned to advertising on YouTube only after developing its own algorithm that ensures its ads are not placed around questionable content.

MM&M's 5 most-read technology stories of 2017

MM&M's 5 most-read technology stories of 2017

By

Digital innovation in Japan, health-tech trends, and social media top the list.

Five things for pharma marketers to know: Wednesday, December 27, 2017

Five things for pharma marketers to know: Wednesday, December 27, 2017

By

Mallinckrodt to buy Sucampo for $1.2 billion; Amazon pushes digital advertising in 2018; WHO classifies gaming disorder as mental health condition

MM&M 2018 staff predictions: From gift bans to Google Assistant

MM&M 2018 staff predictions: From gift bans to Google Assistant

By

From gift bans to Google Assistant, POC to OPDP, MM&M staff members give their predictions on what to expect in healthcare marketing in 2018

Five things for pharma marketers to know: Thursday, December 14, 2017

Five things for pharma marketers to know: Thursday, December 14, 2017

By

Pharma R&D return on investment falls to eight-year low; FDA approves Pfizer's biosimilar to J&J's Remicade; Novartis to downsize generics business